US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 1.480
  • +0.240+19.35%
Close Nov 6 16:00 ET
  • 1.480
  • 0.0000.00%
Post 16:41 ET
379.76MMarket Cap-1783P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q4 -- / 0.000 --
-- 2024/Q3 -- / 0.000 --
-- 2024/Q2 13.000K / 0.000 --
-- 2024/Q1 0.000 / 0.000 --
-- 2023/Q4 13.000K / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q413.000K / 0.000--

Unlock Free Earnings Estimates

Lyell Immunopharma Earnings Reports

  • Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 10:19

  • Lyell Immunopharma | 10-Q: Q1 2024 Earnings Report

    May 6 20:09

  • Lyell Immunopharma | 10-K: FY2023 Annual Report

    Feb 29 11:28

  • Lyell Immunopharma | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 05:14

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 6, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data